Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Pacira BioSciences, Inc. | Chief Medical Officer | Common Stock | 94.3K | $1.89M | $20.05 | Aug 2, 2024 | Direct |
Pacira BioSciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 10K | Jan 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PCRX | Pacira BioSciences, Inc. | Aug 1, 2024 | 2 | -$25.3K | 4 | Aug 2, 2024 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Jun 28, 2024 | 3 | -$95.5K | 4 | Jul 3, 2024 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Jun 11, 2024 | 2 | -$143K | 4 | Jun 13, 2024 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Jun 3, 2024 | 1 | -$49.9K | 4 | Jun 5, 2024 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Dec 6, 2023 | 0 | $0 | 3 | Dec 7, 2023 | Chief Medical Officer |
PCRX | Pacira BioSciences, Inc. | Jun 6, 2023 | 2 | -$36.9K | 4 | Jun 7, 2023 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | Aug 3, 2022 | 1 | -$17.2K | 4 | Aug 5, 2022 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | Jul 5, 2022 | 1 | -$52.8K | 4 | Jul 7, 2022 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | Jun 6, 2022 | 3 | -$22.2K | 4 | Jun 8, 2022 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | May 23, 2022 | 2 | $105K | 4 | May 25, 2022 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Chief Clinical Officer |
PCRX | Pacira BioSciences, Inc. | Jul 20, 2021 | 0 | $0 | 3 | Jul 30, 2021 | Chief Clinical Officer |